3
Most read
5
Most read
6
Most read
MODERN DRUG DISCOVERY PROCESS
Presented By: Rohit R. Chaurpagar
Principles of Drug Discovery
Guided By: Prof V. V. Paithankar Sir
Vidyabharati College Of Pharmacy, Amravati
M Pharm Pharmacology II sem
PYQ Que.
Explain the stages involved in modern drug discovery process.
(summer 2019)
15 Marks
 Drug discovery is therapeutically useful in treating and curing a disease.
 Modern Drug Discovery Process is a process of identifying a compound
therapeutically useful in treating and curing a disease.
 It Involves the identification of :
 Candidates
 Synthesis
 Characterization
 Screening and
 Assays for therapeutic efficacy.
 It is an Expensive process due to the high costs of R&D and human clinical tests.
 The average total cost per drug development varies from US $ 897 million to US$
1.9 billion.
Introduction
Steps in Modern Drug Discovery
Step 1: Target Identification
• A drug target is the specific binding site of a drug
through which the drug exerts its action.
• Characteristics of Target are studied
• The drug target is a receptor, normally a protein.
• The receptor structure change when the Compound
binds to receptor.
• Due to change in the receptor structure various
physiological responses occur and induce regulation
of the cell, organ, tissue, or body status.
• Small molecules binding to the receptors are drugs.
Identify Disease
or condition
Identify receptor
to treat disease
Step 2: Target validation
• Target validation is a process by which the predicted molecular target ( protein or nucleic acid) is
verified
• it prove that manipulating the molecular target can provide therapeutic benefit for patients.
• Target validation process might include following steps:
Discovering a receptor of interest.
Valuating its potential as a target
Designing a bioassay to measure biological activity.
Constructing a high-throughput screen.
Performing screening to find hits.
Evaluating the hits
• Biochemical classes of drug target
 G-Protein coupled receptors -45%
 Enzymes -28%
 Hormones and factors -11%
 Ion channels -5%
 Nuclear receptors -2%
Step 3: Lead discovery
• Lead is a compound that shows possibilities as a treatment for
a disease and may leads the development of new drug
• lead generation phase, help to predict the possible profile of
new drugs in patients.
• The compounds selected are called “leads".
• Between 5 and 50000 compounds are examined in the
laboratory, of which only 100 to 200 are perfected in order to be
tested on systems in vitro and in vivo.
Step 4: Lead optimization
• Molecules are chemically modified in order to obtain compounds with suitable properties to
become a drug.
• Lead optimization is a process that begins with a compound that displays an biological
action and ends with the identification of the best analog.
• Leads are characterized with respect to pharmacodynamic such as efficacy and potency in
vitro and in vivo, Physiochemical properties, pharmacokinetic properties, and toxicological
aspects.
• Potency - refers to the amount of drug required for its specific effect to occur.
• Efficacy - measures the maximum strength of the effect itself, at saturating drug
concentrations.
• Pharmacokinetics - It explains about "What the body does to the drug". It often divided into
areas examining the extent and rate of adsorption, distribution, metabolism, and excretion
(ADME).
• Pharmacodynamic - It determines the biochemical and physiological effects of drugs, the
mechanism of drug action and the relationship between drug concentration and effect. It
explains about "What the drug does to the body".
Step 5: Pre-clinical development
• The pre-clinical development includes the following:
develop large scale synthesis
 animal safety studies
carcinogenicity tests
drug delivery
elimination and metabolism studies
drug formulation experiments
dose-ranging studies in animals.
Wide ranging dosages of the compounds are introduced to the cell line or animal in order to
obtain preliminary efficacy and pharmacokinetic information.
Step 6: Clinical development
• Treatment trials:
test experimental treatments or a new combination of drugs.
• Prevention trials:
look for ways to prevent a disease or prevent it from returning.
• Diagnostic trials:
find better test or procedures for diagnosing a disease.
• Screening trials:
test methods of detecting diseases.
• Quality of life trials:
explore ways to improve comfort & quality of life for individuals with a chronic illness
Reference:
• Principles of Drug Discovery by Padmaja kore first edition
• Chapter 41- Modern drug discovery and Development Science Direct
Article
THAN
K YOU

More Related Content

PPTX
toxicokinetics and saturation kinetics
PDF
Ind enabling studies.
PPTX
IN-VIVO CARCINOGENICITY STUDIES.pptx TG451
PPTX
alternative methods of animal toxicity.pptx
PPTX
Toxicokinetic evaluation in preclinical studies.pptx
PPTX
Female reproductive toxicity studies.pptx
PPTX
Roles and responsibilities in P.V.
PPTX
hit identification.pptx
toxicokinetics and saturation kinetics
Ind enabling studies.
IN-VIVO CARCINOGENICITY STUDIES.pptx TG451
alternative methods of animal toxicity.pptx
Toxicokinetic evaluation in preclinical studies.pptx
Female reproductive toxicity studies.pptx
Roles and responsibilities in P.V.
hit identification.pptx

What's hot (20)

PPTX
Role Of Transgenic Animal In Target Validation-1.pptx
PPTX
HISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptx
PPTX
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
PPTX
Genotoxicity_studies M pharmacy Pharmacology.pptx
PPT
Free radical-pharmacology
PPTX
Toxicokinetic evaluation in preclinical studies.pptx
PPTX
Safety pharmacology tier 2
PPTX
In silico lead discovery technique.pptx
PPTX
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
PPTX
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
PPTX
Safety pharmacology (siri)
PPTX
Guidelines to the Preparation of document.pptx
PPTX
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
PPTX
Role Of Transgenic Animal In Target Validation-1.pptx
PPTX
List of studies needed for IND submission
PPTX
Regulatory guidelines for conducting toxicity studies by ich
PPTX
Alternative methods to animal toxicity testing
PPTX
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
PPTX
Male and female reproductive toxicology
PPTX
Importance and application of toxicokinetics
Role Of Transgenic Animal In Target Validation-1.pptx
HISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
Genotoxicity_studies M pharmacy Pharmacology.pptx
Free radical-pharmacology
Toxicokinetic evaluation in preclinical studies.pptx
Safety pharmacology tier 2
In silico lead discovery technique.pptx
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Safety pharmacology (siri)
Guidelines to the Preparation of document.pptx
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Role Of Transgenic Animal In Target Validation-1.pptx
List of studies needed for IND submission
Regulatory guidelines for conducting toxicity studies by ich
Alternative methods to animal toxicity testing
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
Male and female reproductive toxicology
Importance and application of toxicokinetics
Ad

Similar to Modern drug discovery process|| M pharm Pharmacology.pptx (20)

PPTX
STEPS OF DRUG DISCOVERY AND DEVELOPMENT PROCESS
PPTX
An Overview of Drug Discovery Processes.pptx
PPTX
THERAPUETIC STRATEGIES IN DRUGS PPT.pptx
PDF
stagesofdrugdevelopment-191025161523.pdf
PPTX
Stages of drug development
PDF
1. An Overview of Drug Discovery Process.pdf
PPTX
drug discovery.pptx
PPTX
Complete Drug Discovery Process, AI.pptx
PPTX
OVERVIEW OF MODERN DRUG DISCOVERY PROCESS
PPTX
drug discovery- history, evolution and stages
PPTX
Drug discovery
PDF
Drud Discovery - Dr. Amsavel.pdf
PPTX
New drug development process
PPTX
New drug discovery and development (Part - 1)
PPTX
Drug discovery and development
PPTX
Various process of drug development
PDF
001 introduction to drug discovery
PPTX
DRUG DISCOVERY AND DEVELOPMENT PROCESS OUTLINE, CLINICAL RESEARCH AND ITS PHA...
PPTX
Drug discovery and development
PPT
Drug discovery.ppt
STEPS OF DRUG DISCOVERY AND DEVELOPMENT PROCESS
An Overview of Drug Discovery Processes.pptx
THERAPUETIC STRATEGIES IN DRUGS PPT.pptx
stagesofdrugdevelopment-191025161523.pdf
Stages of drug development
1. An Overview of Drug Discovery Process.pdf
drug discovery.pptx
Complete Drug Discovery Process, AI.pptx
OVERVIEW OF MODERN DRUG DISCOVERY PROCESS
drug discovery- history, evolution and stages
Drug discovery
Drud Discovery - Dr. Amsavel.pdf
New drug development process
New drug discovery and development (Part - 1)
Drug discovery and development
Various process of drug development
001 introduction to drug discovery
DRUG DISCOVERY AND DEVELOPMENT PROCESS OUTLINE, CLINICAL RESEARCH AND ITS PHA...
Drug discovery and development
Drug discovery.ppt
Ad

Recently uploaded (20)

PPTX
Critical Issues in Periodontal Research- An overview
PDF
NCM-107-LEC-REVIEWER.pdf 555555555555555
PDF
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
PDF
periodontaldiseasesandtreatments-200626195738.pdf
PDF
Geriatrics Chapter 1 powerpoint for PA-S
PPTX
Methods of population control Community Medicine
PPTX
abgs and brain death dr js chinganga.pptx
PPTX
sexual offense(1).pptx download pptx ...
PPTX
INDA & ANDA presentation explains about the
PPTX
Peripheral Arterial Diseases PAD-WPS Office.pptx
PPTX
Sanitation and public health for urban regions
PPTX
CASE PRESENTATION CLUB FOOT management.pptx
PPTX
Local Anesthesia Local Anesthesia Local Anesthesia
PPTX
Hypertensive disorders in pregnancy.pptx
PPTX
Biostatistics Lecture Notes_Dadason.pptx
PDF
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
PPTX
IND is a submission to the food and drug administration (FDA), requesting per...
PDF
495958952-Techno-Obstetric-sminiOSCE.pdf
PDF
Integrating Traditional Medicine with Modern Engineering Solutions (www.kiu....
PPT
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
Critical Issues in Periodontal Research- An overview
NCM-107-LEC-REVIEWER.pdf 555555555555555
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
periodontaldiseasesandtreatments-200626195738.pdf
Geriatrics Chapter 1 powerpoint for PA-S
Methods of population control Community Medicine
abgs and brain death dr js chinganga.pptx
sexual offense(1).pptx download pptx ...
INDA & ANDA presentation explains about the
Peripheral Arterial Diseases PAD-WPS Office.pptx
Sanitation and public health for urban regions
CASE PRESENTATION CLUB FOOT management.pptx
Local Anesthesia Local Anesthesia Local Anesthesia
Hypertensive disorders in pregnancy.pptx
Biostatistics Lecture Notes_Dadason.pptx
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
IND is a submission to the food and drug administration (FDA), requesting per...
495958952-Techno-Obstetric-sminiOSCE.pdf
Integrating Traditional Medicine with Modern Engineering Solutions (www.kiu....
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt

Modern drug discovery process|| M pharm Pharmacology.pptx

  • 1. MODERN DRUG DISCOVERY PROCESS Presented By: Rohit R. Chaurpagar Principles of Drug Discovery Guided By: Prof V. V. Paithankar Sir Vidyabharati College Of Pharmacy, Amravati M Pharm Pharmacology II sem
  • 2. PYQ Que. Explain the stages involved in modern drug discovery process. (summer 2019) 15 Marks
  • 3.  Drug discovery is therapeutically useful in treating and curing a disease.  Modern Drug Discovery Process is a process of identifying a compound therapeutically useful in treating and curing a disease.  It Involves the identification of :  Candidates  Synthesis  Characterization  Screening and  Assays for therapeutic efficacy.  It is an Expensive process due to the high costs of R&D and human clinical tests.  The average total cost per drug development varies from US $ 897 million to US$ 1.9 billion. Introduction
  • 4. Steps in Modern Drug Discovery
  • 5. Step 1: Target Identification • A drug target is the specific binding site of a drug through which the drug exerts its action. • Characteristics of Target are studied • The drug target is a receptor, normally a protein. • The receptor structure change when the Compound binds to receptor. • Due to change in the receptor structure various physiological responses occur and induce regulation of the cell, organ, tissue, or body status. • Small molecules binding to the receptors are drugs. Identify Disease or condition Identify receptor to treat disease
  • 6. Step 2: Target validation • Target validation is a process by which the predicted molecular target ( protein or nucleic acid) is verified • it prove that manipulating the molecular target can provide therapeutic benefit for patients. • Target validation process might include following steps: Discovering a receptor of interest. Valuating its potential as a target Designing a bioassay to measure biological activity. Constructing a high-throughput screen. Performing screening to find hits. Evaluating the hits • Biochemical classes of drug target  G-Protein coupled receptors -45%  Enzymes -28%  Hormones and factors -11%  Ion channels -5%  Nuclear receptors -2%
  • 7. Step 3: Lead discovery • Lead is a compound that shows possibilities as a treatment for a disease and may leads the development of new drug • lead generation phase, help to predict the possible profile of new drugs in patients. • The compounds selected are called “leads". • Between 5 and 50000 compounds are examined in the laboratory, of which only 100 to 200 are perfected in order to be tested on systems in vitro and in vivo.
  • 8. Step 4: Lead optimization • Molecules are chemically modified in order to obtain compounds with suitable properties to become a drug. • Lead optimization is a process that begins with a compound that displays an biological action and ends with the identification of the best analog. • Leads are characterized with respect to pharmacodynamic such as efficacy and potency in vitro and in vivo, Physiochemical properties, pharmacokinetic properties, and toxicological aspects. • Potency - refers to the amount of drug required for its specific effect to occur. • Efficacy - measures the maximum strength of the effect itself, at saturating drug concentrations. • Pharmacokinetics - It explains about "What the body does to the drug". It often divided into areas examining the extent and rate of adsorption, distribution, metabolism, and excretion (ADME). • Pharmacodynamic - It determines the biochemical and physiological effects of drugs, the mechanism of drug action and the relationship between drug concentration and effect. It explains about "What the drug does to the body".
  • 9. Step 5: Pre-clinical development • The pre-clinical development includes the following: develop large scale synthesis  animal safety studies carcinogenicity tests drug delivery elimination and metabolism studies drug formulation experiments dose-ranging studies in animals. Wide ranging dosages of the compounds are introduced to the cell line or animal in order to obtain preliminary efficacy and pharmacokinetic information.
  • 10. Step 6: Clinical development • Treatment trials: test experimental treatments or a new combination of drugs. • Prevention trials: look for ways to prevent a disease or prevent it from returning. • Diagnostic trials: find better test or procedures for diagnosing a disease. • Screening trials: test methods of detecting diseases. • Quality of life trials: explore ways to improve comfort & quality of life for individuals with a chronic illness
  • 11. Reference: • Principles of Drug Discovery by Padmaja kore first edition • Chapter 41- Modern drug discovery and Development Science Direct Article